nRichDX Competitors and Similar CompaniesClear all
Mursla's competitors and similar companies include Precipio and Nucleix.
 Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. |  Nucleix Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. | ||
Founding Date | Founding Date 2017 | Founding Date 1997 | Founding Date 2008 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ Milton, GB | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US | Locations Rehovot, IL HQ San Diego, US |
Employees | Employees 16 | Employees 4235% increase | Employees 72 |
Funding | |||
Latest funding round | Latest funding round $ 2m (almost 9 years ago) | Latest funding round N/A | Latest funding round $ 55m (about 5 years ago) |
Total funding raised | Total funding raised $ 2m | Total funding raised $ 1.5m | Total funding raised $ 61m |
For sources of this data, please see the company profile
View Company Profiles
Precipio
HQ
Omaha, US
Employees
42↑ 35% increase
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
View companyNucleix
HQ
Rehovot, IL
Employees
72
Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
View company